|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets | ||||||
| Cash and cash equivalents | ||||||
| Accounts receivable, net | ||||||
| Inventory | ||||||
| Deferred commissions, current | ||||||
| Prepaid expenses and other current assets | ||||||
| Total current assets | ||||||
| Property and equipment, net | ||||||
| Operating lease right-of-use asset | ||||||
| Deferred commissions, non-current | ||||||
| Intangible assets, net | ||||||
| Goodwill | ||||||
| Other assets | ||||||
| Total assets | ||||||
| Liabilities and stockholders’ equity | ||||||
| Current liabilities | ||||||
| Accounts payable | ||||||
| Accrued expenses and other current liabilities | ||||||
| Operating lease liability, current | ||||||
| Deferred revenue | ||||||
| Total current liabilities | ||||||
| Long term debt | ||||||
| Warrant liabilities, non-current | ||||||
| Other liabilities, non-current | ||||||
| Total liabilities | ||||||
| Redeemable convertible preferred stock, $0.001 par value per share; no shares and 120,689 shares authorized as of December 31, 2025 and December 31, 2024, respectively; no shares and 118,219 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively; aggregate liquidation preference of $0 and $455,588 as of December 31, 2025 and December 31, 2024, net of issuance costs | ||||||
| Stockholders’ equity | ||||||
| Common stock, $0.001 par value per share; 750,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 60,607 and 58,429 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total stockholders’ equity | ||||||
| Total liabilities and stockholders’ equity |
Loading...